Dr. Ray Antonio Manneh Kopp

Especialidad: Médico, Oncólogo
País: Colombia

Cargo Actual

Director científico.
Director de investigación clínica.

Lugar de Trabajo

Sociedad de Oncología y Hematología del Cesar
Clínica Porto Azul

Sociedades

ACHO
ASCO
SEOM
SCU
Grupo de oncología Genitourinaria de Colombia.
LACOG

Publicaciones

Immune Checkpoint Inhibitor Combination Therapy versusSunitinib as First-Line Treatment for Favorable-IMDC-RiskAdvanced Renal Cell Carcinoma Patients: A Meta-Analysis ofRandomized Clinical Trials. Biomedicines 2022.
Review Curr Treat Options Oncol. 2022 May 1. High-DoseSomatostatin Analogs for the Treatment of NeuroendocrineNeoplasms: where are we Now? Teresa Alonso-Gordoa, RayManneh, Enrique Grande, Javier Molina-Cerrillo
Management of Patients with Nonmetastatic Castration-Resistant Prostate Cancer: Recommendations of a Multidisciplinary Panel of Experts from South America,” Prostate Cancer, vol. 2021.
Consensus on the Treatment and Follow-Up for the Nonmetastatic Castration-Resistant Prostate Cancer: A Report From the First Prostate Cancer Consensus Conference for Developing Countries. JCO Glob Oncol 2021.
Consensus for Treatment of Metastatic Castration-Sensitive Prostate Cancer: Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC). JCO Glob Oncol 2021
Complete response and renall carcinoma in the immunohterapy era: The paradox of good news. Cancer Treat Rev. 2021.
Impact of COVID-19 infection on patients with cancer: experience in a latin American country: The ACHOCC-19 Study. Oncologist 2021 Oct;26
Combination of statin/vitamin D and metastatic castration-resistant prostate cáncer (CRPC): a post hoc analysis of two randomized clinical trials. Clin Transl Oncol 2020.
Correlation of radiological and immunochemical parameters with clinical outcome in patients with recurrent glioblastoma treated with Bevacizumab. Clin Transl Oncol 2019.
Circulating tumor cells as a biomarker of survival and response to radium-223 therapy: experience in a cohort of patients with metastatic castration-resistant prostate cacner. Clin Genitourin Cancer. 2018.
Urothelial cáncer proteomics provides both prognostic and functional information. Sci Rep. 2017.
Prognostic significance of venous thromboembolic events in disseminated germ cell cáncer patients. J Natl Cancer Inst. 2017
Leakage decrease detected by dynamic susceptibility-weighted contrast-enhanced perfusión MRI predicts survival in recurrent glioblastoma treated with bevacizumab. Clin Transl Oncol 2017.
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and por performance status. Clin Transl Oncol. 2016.
GEINOFOTE: efficacy and safety of fotemustine in patients with high-grade recurrent gliomas and por performance status. Clin Transl Oncol. 2016.
Safety and efficacy of metronomic non-pegylated liposomal encapsulated doxorubicin in heavily pretreated advanced breast cáncer patients. Clin Transl Oncol 2013.